{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:57:26Z","timestamp":1773806246822,"version":"3.50.1"},"reference-count":48,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T00:00:00Z","timestamp":1236902400000},"content-version":"vor","delay-in-days":9325,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacologica et Toxicologica"],"published-print":{"date-parts":[[1983,9]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> Several drugs claimed to protect against anoxic damage to the brain and\/or to aleviate symptoms of senility were tested for their ability to influence purine overflow from hypothalamic synaptosomes. Theophylline did not influence the total purine release but tended to decrease the nucleoside and increase the nucleotide release. Cyclic nucleotide phosphodiesterase inhibitors were ineffective, whereas drugs that inhibit carrier mediated nucleoside transport inhibited veratridine\u2010induced purine release. Some ergot derivatives, some vinca\u2010analogues and the vasodilator ifenprodil also decreased stimulated purine release, but their effect could not be attributed to adenosine transport inhibition. The results suggest that drugs that are reported to aleviate symptoms of anoxic damage or senility may inhibit the release of adenosine and related compounds in the central nervous system. Some possible reasons why a decreased purine release may protect against ischaemic brain damage are discussed.<\/jats:p>","DOI":"10.1111\/j.1600-0773.1983.tb01131.x","type":"journal-article","created":{"date-parts":[[2010,7,29]],"date-time":"2010-07-29T14:06:01Z","timestamp":1280412361000},"page":"236-244","source":"Crossref","is-referenced-by-count":23,"title":["The Effect of Some Drugs with Purported Antianoxic Effect on Veratridine\u2010induced Purine Release from Isolated Rat Hypothalamic Synaptosomes"],"prefix":"10.1111","volume":"53","author":[{"given":"Bertil B.","family":"Fredholm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Lindstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Vernet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,13]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"88","volume-title":"Essays in biochemistry","author":"Arch J. R. S.","year":"1978"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365518009095566"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.35.2.262"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/101.4.687"},{"key":"e_1_2_1_6_1","first-page":"27","volume-title":"Methods of enzymology","author":"B\u00f6hme X.","year":"1974"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(78)91072-7"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1981.55.3.0364"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-3093-6_17"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1980.tb03011.x"},{"issue":"492","key":"e_1_2_1_11_1","first-page":"9","article-title":"Superoxide radical and superoxide dismutases: threat and defense","author":"Brown K.","year":"1980","journal-title":"Actaphysiol. scand."},{"key":"e_1_2_1_12_1","first-page":"25","article-title":"Saturation assay for cyclic AMP using endogenous binding protein","volume":"2","author":"Brown B. L.","year":"1972","journal-title":"Adv. Cyclic Nucl. Res."},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-4127-7"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(81)90583-9"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000135946"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1979.sp013009"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1976.tb10211.x"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(79)90046-4"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1979.tb02402.x"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(76)90467-6"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(80)90117-3"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(78)90199-5"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1982.tb04715.x"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1979.tb06377.x"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1982.tb07142.x"},{"key":"e_1_2_1_26_1","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1016\/S0021-9258(18)62884-4","article-title":"Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase","volume":"215","author":"Fridovich I.","year":"1970","journal-title":"J. Biol. Chem."},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1976.tb04791.x"},{"key":"e_1_2_1_28_1","first-page":"127","volume-title":"Physiological and regulatory functions of adenosine and adenine nucleotides","author":"Gerlach E.","year":"1979"},{"key":"e_1_2_1_29_1","first-page":"138","article-title":"Increased tolerance to cerebral anoxia by pentobarbital","volume":"161","author":"Goldstein A.","year":"1966","journal-title":"Arch. int. Pharmacodyn. Ther."},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4804(75)90067-0"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1976.tb03271.x"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI102568"},{"key":"e_1_2_1_33_1","first-page":"77","article-title":"An effect of aminophylline in experimental cerebral ischemia","volume":"100","author":"Kogure K.","year":"1975","journal-title":"Trans. Amer. Neurol. Assoc."},{"issue":"492","key":"e_1_2_1_34_1","first-page":"1","article-title":"Free radicals in medicine and biology","author":"Lewis D. H.","year":"1980","journal-title":"Acta physiol scand."},{"key":"e_1_2_1_35_1","first-page":"414","article-title":"The effect of ethyl apovincaminate on vasospasm of the circulatory isolated internal carotid artery in dogs","volume":"31","author":"McHedlishvili G. I.","year":"1981","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(75)90107-1"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(75)90048-7"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1640131"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1971.tb07479.x"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1017\/S031716710002521X"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1260965"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00964097"},{"key":"e_1_2_1_43_1","first-page":"592","volume-title":"The pharmacological basis of therapeutics","author":"Rall T. W.","year":"1980"},{"key":"e_1_2_1_44_1","first-page":"141","volume-title":"Development and chemical specificity of neurons. Progress in brain research","author":"Schubert P.","year":"1979"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.5.1.1"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(81)90374-7"},{"key":"e_1_2_1_47_1","first-page":"1238","article-title":"Zur Stellung von Wincamin in der Therapic zerebrovaskul\u00e4rer Krankheiten und zerebraler Leistungsminderungen","volume":"27","author":"Witzmann H. K.","year":"1977","journal-title":"Arzneimittelforsch."},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(81)90387-7"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.3.6.726"}],"container-title":["Acta Pharmacologica et Toxicologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0773.1983.tb01131.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0773.1983.tb01131.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T11:05:02Z","timestamp":1697799902000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0773.1983.tb01131.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1983,9]]}},"alternative-id":["10.1111\/j.1600-0773.1983.tb01131.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0773.1983.tb01131.x","archive":["Portico"],"relation":{},"ISSN":["0001-6683"],"issn-type":[{"value":"0001-6683","type":"print"}],"subject":[],"published":{"date-parts":[[1983,9]]}}}